Baird Says Itron (ITRI) is Ready for Long-Term Growth - Raises PT to $47
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Itron (ITRI) Is In the Early Stages of a Turnaround - Wedbush
February 18, 2016 9:47 AM ESTWedbush analyst, David Rose, thinks that Itron (NASDAQ: ITRI) is in the early stages of a turnaround, based on improving margins and an impressive bookings figure. There is still execution risk but the elements are in place with Q4 results providing good evidence... More
Itron (ITRI) Tops Q4 EPS by 2c, FY Revenue Guidance Comes in Light
February 17, 2016 4:10 PM ESTItron (NASDAQ: ITRI) reported Q4 EPS of $0.76, $0.02 better than the analyst estimate of $0.74. Revenue for the quarter came in at $490.4 million versus the consensus estimate of $486.56 million.
GUIDANCE:
Itron sees FY2016 EPS of $1.95-$2.25, versus the consensus of $2.13. Itron sees... More
Trading Radar for 2/17: Marriott (MAR), NVIDIA (NVDA), Priceline (PCLN), Barrick Gold (ABX), Albemarle (ALB) Report
February 16, 2016 3:29 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
9:15am EST
Industrial Production - Street sees 0.3%Capacity Utilization - Street sees 76.6%Earnings:
AMAG Pharma (Nasdaq: AMAG) - consensus EPS $1.16
Albany Molecular Research (Nasdaq: AMRI) - consensus EPS $0.36... More
